Elevance Health (ELV) Stock Forecast: StockMap's 2-Week Call
ELV stock forecast: StockMap's model leans Outperform on Elevance Health for the two weeks after the Nov 19 close, toward ELV doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Too few two-week windows graded to judge yet.
Elevance Health last closed at $390.16, -2.66% on the session.
Against the IVW growth benchmark the position is -0.33% over the forecast window.
Elevance Health's market cap is $84.30B as of November 19, 2026, #143 in the S&P 500.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 33 (too close to call).
Where ELV sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 7 bullish and 8 bearish.
Agreement across those insights is 47%.
11 daily calls for ELV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Elevance Health in the 54th percentile on valuation and the 64th percentile on return on equity, where 100 is best.
Elevance Health is classified under Health Care / Health Care Providers & Services.
StockMap tracks Elevance Health as the 5th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite Elevance Health ranks 3rd of 87 in the group, against a group median of -0.06.